By Maria Garcia-Jimenez, MD/MHS, Abinav Baweja, MD, and Nicole LaNatra, MD
Peer Reviewed
Clinical vignette
A 65-year old woman with history of invasive breast cancer presents to her primary care provider for regular …
Category: Heme/Onc
Clinical Correlations
Core IM podcast: 5 Pearls on Iron Deficiency Anemia
November 15, 2017
Listen to 5Â Pearls segment of Iron Deficiency Anemia! By Dr. Cary Blum MD, Marty Fried MD and Shreya P. Trivedi MD; Illustration by Mike Natter MD
Time Stamps:
- Â Should patients be …
Reducing Readmission in Sickle Cell Disease: The Role of the Patient-Centered Medical Home
October 6, 2017
By Leonard Naymagon, MD
Peer Reviewed
Vaso-occlusive crisis (VOC), or pain crisis, is the most common clinical manifestation of sickle cell disease (SCD) and is responsible for the majority of emergency department (ED) visits …
Sex or Drugs: Why Do We See An Increased Incidence of Oropharyngeal Cancer?
July 13, 2016
By Tyler Litton, MD
Peer Reviewed
Oropharyngeal squamous cell carcinoma (OPSCC) is relatively rare but incidence has increased in the US over the past 40 years. [1] Tonsillar cancer is the …
Shifting Paradigms in Cancer: Vaccines
January 22, 2015
Joshua Horton
Peer Reviewed
We are not winning the war against cancer, if war is even an appropriate metaphor. When Richard Nixon signed the National Cancer Act into effect in 1971, many …
Lung Cancer Screening with Low-Dose CT Scans
May 9, 2014
By Susanna Jeurling
Peer Reviewed
The U.S. Preventive Services Task Force (USPSTF) recently finalized its position regarding annual low-dose computed tomography (LDCT) scanning for early detection of lung cancer. The grade B …
From The Archives: Should My Patient with a Solid Tumor be Anticoagulated in the Absence of Venous Thromboembolism?
March 6, 2014
Please enjoy this post from the archives dated September 8, 2011
By David Altszuler, Class of 2012
Faculty Peer Reviewed
An empiric association between occult malignancy and thrombophlebitis has been recognized since Trousseau first reported the syndrome in 1865.[1] The …
An antidote on the horizon? An update on the progress toward achieving reversibility for the new oral anticoagulants
February 21, 2014
By Gabriel Schneider, MD
Peer Reviewed
The new oral anticoagulants (NOACs) are an appealing alternative to the burdensome vitamin K antagonists such as warfarin. These novel agents include direct thrombin inhibitors such …